Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Aul

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 7, 2018
C Aul
Cancer|November 1, 1989
The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromesC Aul, W Schneider
Praxis|January 16, 1996
[Diagnosis and therapy strategy in myelodysplastic syndromes]N Gattermann, C Aul
British Journal of Haematology|April 1, 1997
Mitochondrial DNA amplification in AML: a hypothesisN Gattermann, C Aul
Acta Medica Austriaca|January 1, 1979
[Heterozygous beta-thalassemia in a large German family]W Schneider, C Aul
Deutsche Medizinische Wochenschrift (1946)|May 17, 1996
[Indications for chemotherapy in multiple myeloma]A Heyll, C Aul
Deutsche Medizinische Wochenschrift (1946)|November 30, 1990
[The therapy of myelodysplastic syndromes]C Aul, A Heyll
Haematology and Blood Transfusion|January 1, 1987
Contribution of clonogenic leukemic cell characteristics to therapy outcome in patients with acute myeloblastic leukemiaC Aul, A Heyll
Fortschritte Der Medizin|February 17, 1983
[Long-term therapy in leukemias and malignant lymphomas]C Aul, W Schneider
Mycoses|January 1, 1994
[Prophylaxis against mycoses in neutropenic patients]M Arning, C Aul
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 7, 2018
C Aul
Cancer|November 1, 1989
The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromesC Aul, W Schneider
Praxis|January 16, 1996
[Diagnosis and therapy strategy in myelodysplastic syndromes]N Gattermann, C Aul
British Journal of Haematology|April 1, 1997
Mitochondrial DNA amplification in AML: a hypothesisN Gattermann, C Aul
Acta Medica Austriaca|January 1, 1979
[Heterozygous beta-thalassemia in a large German family]W Schneider, C Aul
Deutsche Medizinische Wochenschrift (1946)|May 17, 1996
[Indications for chemotherapy in multiple myeloma]A Heyll, C Aul
Deutsche Medizinische Wochenschrift (1946)|November 30, 1990
[The therapy of myelodysplastic syndromes]C Aul, A Heyll
Haematology and Blood Transfusion|January 1, 1987
Contribution of clonogenic leukemic cell characteristics to therapy outcome in patients with acute myeloblastic leukemiaC Aul, A Heyll
Fortschritte Der Medizin|February 17, 1983
[Long-term therapy in leukemias and malignant lymphomas]C Aul, W Schneider
Mycoses|January 1, 1994
[Prophylaxis against mycoses in neutropenic patients]M Arning, C Aul
Pageof 18